Navigation Links
Isis Reports Financial Results and Highlights for 2012
Date:2/28/2013

$170.2 million for the same periods in 2011.Early Retirement of Debt
In August 2012, Isis issued $201.3 million of 2 ¾% convertible senior notes due 2019 (2 ¾% Notes).  In September 2012, Isis used a substantial portion of the net proceeds from the issuance of these notes to redeem the entire $162.5 million of the Company's 2 ⅝% convertible subordinated notes (2 ⅝% Notes). As a result of the early redemption of the 2 ⅝% Notes, Isis recognized a $4.8 million loss primarily related to a non-cash write-off of the unamortized portion of the debt discount and debt issuance costs. 

Gain on Investment in Regulus Therapeutics Inc.
In October 2012, Regulus Therapeutics, Inc., a company Isis co-founded, completed an initial public offering.  In the fourth quarter, as a result of the IPO, Isis recorded an $18.4 million gain to reflect the Company's change in its ownership percentage in Regulus. Also in the fourth quarter, Isis stopped using the equity method to account for its investment in Regulus and instead began accounting for it at fair value.  Isis now owns approximately seven million shares, or 17%, of Regulus' common stock on a fully diluted basis. 

Net Loss
Isis reported a net loss of $2.6 million and $65.5 million for the three and twelve months ended December 31, 2012, respectively, compared to $20.0 million and $84.8 million for the same periods in 2011.  Basic and diluted net loss per share for the three and twelve months ended December 31, 2012 was $0.03 per share and $0.65 per share, compared to $0.20 per share and $0.85 per share for the same periods in 2011.  In 2012, Isis' net loss was significantly lower than 2011 primarily due to the $18.4 million gain from its investment in Regulus and the related $9.1 million tax benefit offset, in part, by an increase in Isis' net operating loss, the $4.8 million loss on Isis' early retirement of its 2 ⅝% N
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. NxStage Reports Record Fourth Quarter and Full-Year 2012 Financial Results
2. Valeant Pharmaceuticals Reports 2012 Fourth Quarter Financial Results
3. Mylan Reports a 23% Increase in Fourth Quarter 2012 Adjusted Diluted EPS to $0.65
4. HeartWare International Reports Fourth Quarter 2012 Revenue Of $32.7 Million; Full Year 2012 Revenue Of $110.9 Million
5. ViroPharma Incorporated Reports Fourth Quarter and Full Year 2012 Financial Results
6. Kewaunee Scientific Reports Improved Results for Third Quarter
7. Jazz Pharmaceuticals Reports Full Year And Fourth Quarter 2012 Financial Results
8. Questcor Reports Fourth Quarter and Full Year 2012 Results
9. ResearchMoz: Global MRI Systems Market to 2018 - Technological Advancements, Increasing Number of Applications and Advent of MRI Compatible Pacemakers to Drive Future Growth - Market Research Reports
10. United Therapeutics Corporation Reports 2012 Fourth Quarter and Annual Financial Results
11. Halozyme Reports Fourth Quarter and Year End 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... 28, 2015 Research and ... the "Investigation Report on China,s Bevacizumab Market ,2010-2019" ... Roche under the trade name of Avastin, bevacizumab injection ... Feb.26, 2010, it was approved by CFDA to treat ... China all come from Roche and ...
(Date:8/28/2015)... -- Today, in final recognition of the Centers for Disease ... Contacts is sharing how to keep lens cases clean.  ... do not properly care for their lens cases are ... Most contact lens wearers understand the importance of ... is sometimes overlooked.  When proper steps to clean a ...
(Date:8/28/2015)... Aug. 28, 2015 ... addition of the "Investigation Report on China,s ... offering. Developed by Novo Nordisk, insulin ... an important drug for the treatment of diabetes. ... fast- acting insulin analog, starts working fast and ...
Breaking Medicine Technology:Investigation Report on China's Bevacizumab Market 2015-2019 21-800 Contacts Shares Tips on How to Clean Lens Cases 2China Insulin Aspart Market Report 2010-2019 - Developed by Novo Nordisk 2
... MYL ) today announced that it, along ... agreement with Warner Chilcott resolving litigation related to Femcon® ... Estradiol Tablets USP (Chewable), 0.4 mg/0.035 mg and Ferrous ... medication is an oral contraceptive. Pursuant to ...
... Oct. 19, 2011 Uroplasty, Inc. (NASDAQ: UPI ... the second quarter of fiscal 2012 ended September 30, 2011, ... Company will host a conference call to discuss these results ... (3:30 p.m. Central Time). David Kaysen, President and Chief Executive ...
Cached Medicine Technology:Mylan Announces Femcon® Fe Settlement Agreement 2Uroplasty to Issue Second Quarter 2012 Financial Results on October 27, 2011 2
(Date:8/29/2015)... ... August 29, 2015 , ... The popular television program ... Jones, recently announced that it will be devoting an entire short segment to the ... of people around the globe on a daily basis, but recent advancements in medical ...
(Date:8/28/2015)... ... August 28, 2015 , ... ... Decatur County Memorial Hospital recently transitioned management companies to partner with Wound Care ... for their outpatient wound center. , Transitioning wound care management providers can ...
(Date:8/28/2015)... ... 2015 , ... The Kentucky State Department of Workforce Investment Commissioner Beth Kuhn ... applying for, they are unable to pass the initial drug test and therefore unable ... in order to be able to hire long-term, skilled talent. (1) Will Wesch, Director ...
(Date:8/28/2015)... (PRWEB) , ... August 28, 2015 , ... For Dallas, ... is taking part with their subsidiary USPI Tenet Health. , The American Heart Association ... heart disease and stroke. They believe that together, a difference can be made. Walkers ...
(Date:8/28/2015)... (PRWEB) , ... August 28, 2015 , ... The ... the renowned Brain Aneurysm Foundation has added yet another accolade to its cadre of ... Emanuel. , “With the help of the medical community and the University ...
Breaking Medicine News(10 mins):Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 2Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 3Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 4Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 2Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 3Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 4Health News:North Central Surgical Center’s Subsidiary Participates in Walk 2Health News:Chicago Mayor Pens Official Support of Annual Survivor in the City Event Benefitting Brain Aneurysm Foundation 2Health News:Chicago Mayor Pens Official Support of Annual Survivor in the City Event Benefitting Brain Aneurysm Foundation 3
... HealthDay Reporter , WEDNESDAY, Feb. 23 (HealthDay News) -- ... be attached to a smart phone and diagnose cancerous ... The so-called microNMR chip, which uses magnetic nanoparticles to ... only tiny amounts of tissue to make a diagnosis, ...
... Diego are developing nonsurgical methods for identifying critical lymph ... breast cancer patients. The "sentinel lymph node" is routinely ... that the cancer has spread beyond the breast. ... Department of Nanoengineering in the UC San Diego Jacobs ...
... , WEDNESDAY, Feb. 23 (HealthDay News) -- ... high blood levels of a stress-related hormone, new research ... (PACAP) -- is known to affect central nervous system ... In the new study, published in the Feb. ...
... for schizophrenia research, an international team of scientists led by ... involving Trinity College Dublin researchers has identified a gene mutation ... target for the development of drug therapies. The findings are ... Nature . Schizophrenia is a chronic, severe and ...
... The main active ingredient in marijuana seems to allow chemotherapy ... according to the results of a small new study. ... cancer patients restore their appetite. Chemotherapy patients often lose ... them to lose an unhealthy amount of weight. Researchers at ...
... HOUSTON - While studying one tumor-suppressing protein, Cheryl Walker,s ... Cancer Center came across a separate surprise. They found ... nucleus moonlighting out in the cell,s cytoplasm. Following ... nuclear protein ATM has a second job controlling and ...
Cached Medicine News:Health News:Microchip Spots Cancerous Tumors Within an Hour, Study Shows 2Health News:Microchip Spots Cancerous Tumors Within an Hour, Study Shows 3Health News:Microbubbles to light the way to sentinel lymph nodes of breast cancer patients 2Health News:Discovery of new gene mutation in schizophrenia offers a new target for drug therapies 2Health News:Pot Ingredient May Restore Appetite After Chemo 2Health News:UT MD Anderson discovery wins 2010 Cozzarelli Prize 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: